Mahzi Therapeutics
Mahzi Therapeutics is a startup headquartered in South San Francisco, United States, founded in 2020. It has raised at least $52.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Mahzi Therapeutics has raised at least $52.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Mahzi Therapeutics sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in South San Francisco
- Addition Therapeutics
- Asher Biotherapeutics
- Burnbot
- Dualitas Therapeutics
- Firefly Bio
- Kamau Therapeutics
- Long Bridge Medical
- Lycia Therapeutics
- Moonwalk Biosciences
- NewLimit
- NGM Bio Holdings
Related
- Innovation profile of South San Francisco
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Mahzi Therapeutics do?
Mahzi Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Mahzi Therapeutics raised?
At least $52.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Mahzi Therapeutics based?
Mahzi Therapeutics is headquartered in South San Francisco, United States.
When was Mahzi Therapeutics founded?
Mahzi Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.